Vertex Pharmaceuticals
VRTX
#178
Rank
โ‚น10.523 T
Marketcap
โ‚น41,044
Share price
-0.24%
Change (1 day)
19.22%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): โ‚น386.38 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are โ‚น11.72 Billion. In 2024 the company made an earning of โ‚น24.94 Billion a decrease over its 2023 earnings that were of โ‚น395.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น386.38 B1448.91%
2024 โ‚น24.94 B-93.69%
2023 โ‚น395.40 B3.19%
2022 โ‚น383.18 B53.56%
2021 โ‚น249.54 B-12.06%
2020 โ‚น283.77 B118.45%
2019 โ‚น129.90 B120.64%
2018 โ‚น58.87 B1473.64%
2017 โ‚น3.74 B197.6%
2016 โ‚น1.25 B-102.97%
2015 -โ‚น42.33 Billion-28.46%
2014 -โ‚น59.17 Billion-51.5%
2013 -โ‚น122.02 Billion-30584.68%
2012 โ‚น0.40 B-95.47%
2011 โ‚น8.83 B
2009 -โ‚น52.99 Billion
2007 -โ‚น36.89 Billion83.1%
2006 -โ‚น20.15 Billion59.02%
2005 -โ‚น12.67 Billion3.28%
2004 -โ‚น12.27 Billion-38.16%
2003 -โ‚น19.84 Billion
2000 -โ‚น3.41 Billion-20.38%
1999 -โ‚น4.28 Billion31.62%
1998 -โ‚น3.25 Billion91.05%
1997 -โ‚น1.7 Billion-36.24%
1996 -โ‚น2.67 Billion12.45%
1995 -โ‚น2.37 Billion27.4%
1994 -โ‚น1.86 Billion-1833.33%
1993 โ‚น0.10 B-112.12%
1992 -โ‚น0.89 Billion175%
1991 -โ‚น0.33 Billion-12.2%
1990 -โ‚น0.37 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น883.60 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น148.36 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.063 T 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น717.98 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.895 T 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-โ‚น6.79 Billion-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA